Sanity Group
Press

Sanity Group

Unlocking the health benefits of cannabinoids
After decades of scientific negligence of the cannabis plant, more and more research is proving what people already knew thousands of years ago: That cannabis can have a positive impact on peoples’ lives. Therefore, it is our purpose to develop innovative cannabinoid-based pharmaceuticals and wellbeing products, as well as make them widely accessible. To utilize the full potential of its health benefits, Sanity Group is investing in fundamental research of the cannabis plant and its active ingredients as well as in specific areas of application. Equipped with this knowledge, we educate healthcare professionals, patients and consumers and support them to live a healthier life.
Contact

You would like to write about Sanity Group or one of its brands, are planning an interview or are looking for an expert on the topic of medical cannabis? Let’s get in touch! Just contact us by email or give us a call.

Sanity Group

Unlocking the health benefits of cannabinoids

After decades of scientific negligence of the cannabis plant, more and more research is proving what people already knew thousands of years ago: That cannabis can have a positive impact on peoples’ lives. Therefore, it is our purpose to develop innovative cannabinoid-based pharmaceuticals and wellbeing products, as well as make them widely accessible. To utilize the full potential of its health benefits, Sanity Group is investing in fundamental research of the cannabis plant and its active ingredients as well as in specific areas of application. Equipped with this knowledge, we educate healthcare professionals, patients and consumers and support them to live a healthier life.

Contact

You would like to write about Sanity Group or one of its brands, are planning an interview or are looking for an expert on the topic of medical cannabis? Let’s get in touch! Just contact us by email or give us a call.

Our three pillars

Medical

Together with our partners, we research and develop innovative cannabinoid-based pharmaceuticals and make them accessible and available to pharmacists, physicians and patients all over Europe.

Wellbeing

Sanity Group’s companies work on various CBD based wellbeing products. By making our products accessible through online and offline channels, it is our goal to improve the quality of life of our consumers.

Ancillary

In parallel, we are working on medical products, new innovative dosage forms, and technological products and services to further develop the infrastructure of the entire industry.

Brands

VAAY-logo

VAAY is bringing the all-goodness-zero-badness magic of CBD to the wellbeing category and redefines what it means to find relief.

Vayamed_Logo-web-768x182

Vayamed GmbH is developing and selling medicinal cannabis products to pharmacies and clinical institutions.

ThisPlace_Logo-Dark_1200x1200-300x300
This Place creates a new kind of natural wellness and beauty products. Its cosmetic creams support body and mind in a sustainable way and help you regain personal balance in everyday life.
belfry-logo-black-e1599488686312-768x432

more infos coming soon!

Media Library

Press photos

Reference: Sanity Group ©

To the selection

Logos

Reference: Sanity Group ©

To the selection

Dates & Facts

Finn A. Hänsel and Fabian Friede founded the Berlin-based company Sanity Group in 2018 with the aim of supplying people in Europe with cannabis-based medicines and health products while building up the necessary infrastructure. Today, a diverse team of around 80 people, including scientists, medical professionals and entrepreneurs, work for Sanity Group at its headquarter in Berlin-Mitte.

For the two founders, the sensible use of cannabis, opposite to the plants stoner image, is a topic that has accompanied them for a long time: While Finn Hänsel already campaigned for the decriminalization of cannabis and legal sales, e.g. in 2002 as the district chairman of the “Flensburg Junge Union” in Schleswig-Holstein, Fabian Friede has witnessed in his family how important, but also difficult, it is for patients with serious illness to be supplied with the appropriate medication in pain therapy. Since 2017, cannabinoids can be prescribed in cases of serious physical illnesses; however, many doctors still have no experience in prescribing cannabis; there are also problems with dispensing it in pharmacies. Fabian Friede and Finn Hänsel want to change this.

Development, Research, Sales

Sanity Group’s portfolio is broad and innovative: Sanity Group is active in the B2B sector, currently primarily with its subsidiary Vayamed. The pharmaceutical company develops and distributes medical cannabis to doctors and pharmacies. In parallel, it is working and researching medical products, new innovative dosage forms, and technological products and services to further develop the infrastructure of the entire industry. With its consumer well-being brands VAAY and This Place, the company also covers the B2C business, with VAAY focusing on CBD products such as oils, bath bombs and mouth sprays to help people achieve more balance in their everyday lives. CBD is a non-psychoactive active ingredient from the cannabis plant – it does not make people “high” or dependent, but is said to have a relaxing effect. While the lifestyle brand VAAY appeals to a young, urban target group, This Place, with creams such as face, sleep, muscle and PMS creams, represents the cosmetics line and is aimed particularly at a target group between 35 and 50 years of age.

Info & Factsheet (PDF)

Vita Founders (PDF)

Finn-821x1024

“In the midst of ongoing cannabis legalizations in North America and other parts of the world, Europe is forging its own path. With more than 700 million inhabitants in continental Europe and 500 million within the EU, the market for cannabis is estimated to exceed 100 billion euros by 2028. Sanity Group is engaged with the very different markets within Europe, each of which has its own regulations, healthcare system and needs.” (Translated from German)

Finn A. Hänsel, Founder & Managing Director

“When you hear stories of people who have suffered from the side effects of a particular medication for a long time, and their quality of life has improved because of a cannabis product – that’s reason enough to keep researching it. Currently, many doctors, pharmacists and patients are often unaware of the medical benefits that cannabis has to offer. This is where we want to raise awareness – and will also invest in research. Because what some people still associate with the plant is based on old prejudices.” (Translated from German)

Fabian Friede, Founder & Managing Director

Fabian-768x958

Press

Subscribe to press releases

We are happy to provide journalists, bloggers and media representatives with relevant information about Sanity Group on a regular basis. Subscribe to our press distribution list to receive important news from us directly in the future.

We also appreciate you keeping us informed about publications. Feel free to send us a copy (ideally as PDF) to presse@sanitygroup.com. Thank you very much!